Annual EBIT:
-$216.87M-$123.87M(-133.19%)Summary
- As of today, APGE annual earnings before interest & taxes is -$216.87 million, with the most recent change of -$123.87 million (-133.19%) on December 31, 2024.
- During the last 3 years, APGE annual EBIT has fallen by -$186.24 million (-607.92%).
- APGE annual EBIT is now -607.92% below its all-time high of -$30.64 million, reached on December 31, 2022.
Performance
APGE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$71.28M+$1.89M(+2.58%)Summary
- As of today, APGE quarterly earnings before interest & taxes is -$71.28 million, with the most recent change of +$1.89 million (+2.58%) on September 30, 2025.
- Over the past year, APGE quarterly EBIT has dropped by -$12.59 million (-21.46%).
- APGE quarterly EBIT is now -3825.00% below its all-time high of -$1.82 million, reached on June 1, 2022.
Performance
APGE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$283.42M-$12.59M(-4.65%)Summary
- As of today, APGE TTM earnings before interest & taxes is -$283.42 million, with the most recent change of -$12.59 million (-4.65%) on September 30, 2025.
- Over the past year, APGE TTM EBIT has dropped by -$105.28 million (-59.10%).
- APGE TTM EBIT is now -6483.51% below its all-time high of -$4.30 million, reached on March 1, 2022.
Performance
APGE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APGE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -133.2% | -21.5% | -59.1% |
| 3Y3 Years | -607.9% | -578.4% | -1604.5% |
| 5Y5 Years | -607.9% | -1555.7% | -6483.5% |
APGE EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -607.9% | at low | -578.4% | +6.1% | -1604.5% | at low |
| 5Y | 5-Year | -607.9% | at low | -3825.0% | +6.1% | -6483.5% | at low |
| All-Time | All-Time | -607.9% | at low | -3825.0% | +6.1% | -6483.5% | at low |
APGE EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$71.28M(+2.6%) | -$283.42M(-4.6%) |
| Jun 2025 | - | -$73.17M(-16.0%) | -$270.83M(-12.0%) |
| Mar 2025 | - | -$63.10M(+16.8%) | -$241.78M(-11.5%) |
| Dec 2024 | -$216.87M(-133.2%) | -$75.88M(-29.3%) | -$216.87M(-21.7%) |
| Sep 2024 | - | -$58.69M(-33.0%) | -$178.14M(-23.9%) |
| Jun 2024 | - | -$44.12M(-15.6%) | -$143.76M(-21.3%) |
| Mar 2024 | - | -$38.18M(-2.8%) | -$118.53M(-27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$93.00M(-203.6%) | -$37.16M(-52.9%) | -$93.00M(-66.5%) |
| Sep 2023 | - | -$24.30M(-28.7%) | -$55.85M(-32.8%) |
| Jun 2023 | - | -$18.89M(-49.2%) | -$42.05M(-68.3%) |
| Mar 2023 | - | -$12.66M(-20.5%) | -$24.98M(-50.2%) |
| Dec 2022 | -$30.64M | - | - |
| Sep 2022 | - | -$10.51M(-478.6%) | -$16.63M(-171.7%) |
| Jun 2022 | - | -$1.82M(+57.8%) | -$6.12M(-42.2%) |
| Mar 2022 | - | -$4.30M | -$4.30M |
FAQ
- What is Apogee Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual EBIT year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Apogee Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM EBIT year-on-year change?
What is Apogee Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of APGE is -$216.87M
What is the all-time high annual EBIT for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$30.64M
What is Apogee Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, APGE annual earnings before interest & taxes has changed by -$123.87M (-133.19%)
What is Apogee Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of APGE is -$71.28M
What is the all-time high quarterly EBIT for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$1.82M
What is Apogee Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, APGE quarterly earnings before interest & taxes has changed by -$12.59M (-21.46%)
What is Apogee Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of APGE is -$283.42M
What is the all-time high TTM EBIT for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$4.30M
What is Apogee Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, APGE TTM earnings before interest & taxes has changed by -$105.28M (-59.10%)